EUCTR2011-005650-54-FI进行中(未招募)不适用
Prothrombin complex concentrate in the reduction of blood loss during otrhotopic liver transplantation. - PROTON trial
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •->18 years
- •-Eligible for orthotopic liver transplantation
- •-INR>1.5
- •-Signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Previous liver transplantation
- •-Split liver transplantation
- •-Heterotopic liver transplantation
- •-Scheduled multiorgan transplantation,
- •-Scheduled living related-donor transplantation
- •-Renal insufficiency requiring dialysis
- •-Documented congenital coagulation disorders
- •-Documented history or presence of arterial or venous thrombosis
- •-Treatment with warfarin/coumarin
- •-TIPS (transjugular intrahepatic portosystemic shunt)
- •-Fulminant hepatic failure
- •-Documented coronary artery disease
- •-Documented thrombophilia
研究者
相似试验
进行中(未招募)
不适用
Prothrombin complex concentrate in liver transplantatioEUCTR2011-005650-54-NLniversity Medical Center Groningen140
进行中(未招募)
不适用
Prothrombin complex concentrate in liver transplantatioEUCTR2011-005650-54-BEniversity Medical Center Groningen140
已完成
4 期
Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation.Bleedinghemorrhage10064477NL-OMON40112niversitair Medisch Centrum Groningen60
招募中
不适用
Prothrombin Complex Concentrate in the reduction of blood loss during orthotoppic liver transplantation.cirrhosisbleedinghemorrhagecomplicationshemostasiscoagulationNL-OMON28249Sanquin Plasma Products140
招募中
不适用
Prothrombin complex concentrate (Cofact ®) as a potential antidote for novel anticoagulants Dabigatran and Rivaroxaban.Anticoagulants.Antidote for bleeding.NL-OMON22423Prof. dr. M.M. Levi, Academic Medical Centre of Amsterdam12
